Macronutrient group symposium on 'dietary determinants of lipoprotein-mediated cardiovascular risk'. Lipoprotein atherogenicity: An overview of current mechanisms

Proceedings of the Nutrition Society

Volumn 58, Issue 1, 1999, Pages 163-169

  Griffin, Bruce A ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

CHD; Postprandial metabolism; Small dense LDL; Triacylglycerols

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; FOOD COMPOSITION; HUMAN; INSULIN RESISTANCE; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MEDICAL LITERATURE; MOLECULAR DYNAMICS; PARTICLE SIZE; PROTEIN TRANSPORT; TRIACYLGLYCEROL BLOOD LEVEL;

ARTERIOSCLEROSIS; CHOLESTEROL; CORONARY DISEASE; HUMANS; LIPOPROTEINS, LDL; PARTICLE SIZE; RISK FACTORS; TRIGLYCERIDES;

EID: 0032908523     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/pns19990022     Document Type: Conference Paper

References (36)

1. Anber V, Griffin BA, McConnell M, Packard CJ & Shepherd J (1996) Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 124, 261-271.
2. Anitshkow N (1913) Changes in rabbit aorta due to experimentally induced cholesterolsteatosis. Beitrage zur pathologishen Antatomie und zur allegemeinen Pathologie 56, 379-404.
3. Assman GM, Schulte H, von Eckardstein A & Huang Y (1996) High density lipoprotein cholesterol is a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124, Suppl., S11-S20.
4. Austin MA, Breslow JL, Hennekens CH, Burling JE, Willett WC & Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association 260, 1917-1921.
5. Austin MA, King MC, Vranizan KM & Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease. Arteriosclerosis and Thrombosis 82, 495-506.
6. Bjorkegren J, Packard CJ, Hamsten A, Bedford D, Caslake MJ, Foster L, Shepherd J, Stewart P & Karpe F (1996) Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. Journal of Lipid Research 37, 76-86.
7. Brown MS, Faust JR & Goldstein JL (1975) Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. Journal of Clinical Investigation 55, 783-793.
8. Castelli WP (1984) Epidemiology of coronary heart disease: The Framingham study. American Journal of Medicine 76, 4-12.
9. Despres JP & Marette A (1994) Relation of components of insulin resistance syndrome to coronary heart disease risk. Current Opinion in Lipidology 5, 274-289.
10. Fisher RM, Coppack SW, Gibbons GF & Frayn KN (1993) Postprandial VLDL subfraction metabolism in normal and obese subjects. International Journal of Obesity 17, 263-269.
11. Fruchart JC & Packard CJ (1997) Is cholesterol the major lipoprotein risk factor in coronary heart disease? - a Franco-Scottish overview. Current Medical Research and Opinion 13, 603-616.
12. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen TD, Gleeson A, Arad Y, Witte L, Al-Haideri M, Rumsey SC & Deckelbaun RJ (1994) Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small, dense LDL but not in triglyceride-rich LDL of normal size. Journal of Biological Chemistry 269, 511-519.
13. Gardner CD, Fortmann SP & Krauss RM (1996) Association of small, low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Journal of the American Medical Association 276, 875-881.
14. Gofman JW, Lindgren F, Elliott H, Mantz W, Hewitt J, Strisower B & Herring V (1950) The role of lipids and lipoproteins in atherosclerosis. Science 111, 166-186.
15. Goldstein JL, Ho YK, Basu SK & Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proceedings of the National Academy of Sciences USA 76, 333-337.
16. Griffin BA (1997) Low-density lipoprotein subclasses: mechanisms of formation and modulation. Proceedings of the Nutrition Society 56, 693-702.
17. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ & Shepherd J (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241-253.
18. Hokanson J & Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213-219.
19. James RW & Pometta D (1991) The distribution profiles of very low density and low density lipoproteins in poorly-controlled male. Type 2 (non-insulin dependent) diabetic patients. Diabetologia 34, 246-252.
20. Keys A (1970) Coronary heart disease in seven countries. Circulation 41, Suppl. 1, I-186-I-198.
21. Millar JS & Packard CJ (1998) Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies. Current Opinion in Lipidology 9, 197-202.
22. Nigon F, Lesnik P, Rouis M & Chapman MJ (1991) Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. Journal of Lipid Research 32, 1741-1753.
23. Nordestgaard BG & Nielsen LB (1994) Atherosclerosis and arterial influx of lipoproteins. Current Opinion in Lipidology 5, 252-257.
24. Packard CJ (1995) Lipid exchanges. Micro News 1, 1-8.
25. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 383-389.
26. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH & Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia: West of Scotland Coronary Prevention Study Group. New England Journal of Medicine 333, 1301-1307.
27. Shepherd J & Packard CJ (1987) Metabolic heterogeneity in very low density lipoproteins. American Heart Journal 113, 503-508.
28. Smith EB & Slater RS (1972) Relationship between low-density lipoprotein in aortic intima and serum-lipid levels. Lancet i, 463-469.
29. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B & Kwiterovich PO (1980) Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (beta) lipoprotein. Proceedings of the National Academy of Sciences USA 77, 604-608.
30. Sniderman AD, Cianflone K, Arner P, Summers LKM & Frayn KN (1998) The adipocyte, fatty acid trapping, and atherogenesis. Arteriosclerosis, Thrombosis and Vascular Biology 18, 147-151.
31. Stamler J, Wentworth D & Neaton JD (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? The Multiple Risk Factor Intervention Trial. Journal of the American Medical Association 256, 2823-2828.
32. Stampfer MJ, Krauss RM, Blanche PJ, Holl LG, Sacks FM & Hennekens CH (1996) A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. Journal of the American Medical Association 276, 882-888.
33. Steinberg D & Witztum JL (1990) Lipoproteins and atherogenesis. Journal of the American Medical Association 264, 3047-3052.
34. Tan CE, Forster L, Caslake MJ, Bedford D, Watson TDG, McConnell M, Packard CJ & Shepherd J (1995) Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1839-1848.
35. Tribble DL, Holl LG, Wood PD & Krauss RM (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93, 189-199.
36. Tribble DL, Krauss RM, Landsberg MG, Thiel PM & Berg JM (1995) Greater oxidative susceptibility of the surface monolayer in small, dense LDL may contribute to differences in copper-induced oxidation among LDL subfractions. Journal of Lipid Research 36, 662-671.